Effect of age and the APOE gene on metabolite concentrations in the posterior cingulate cortex.
Scientific Abstract
Proton magnetic resonance spectroscopy (H-MRS) has provided valuable information about the neurochemical profile of Alzheimer's disease (AD). However, its clinical utility has been limited in part by the lack of consistent information on how metabolite concentrations vary in the normal aging brain and in carriers of apolipoprotein E (APOE) ε4, an established risk gene for AD. We quantified metabolites within an 8cm voxel within the posterior cingulate cortex (PCC)/precuneus in 30 younger (20-40 years) and 151 cognitively healthy older individuals (60-85 years). All H-MRS scans were performed at 3T using the short-echo SPECIAL sequence and analyzed with LCModel. The effect of APOE was assessed in a sub-set of 130 volunteers. Older participants had significantly higher myo-inositol and creatine, and significantly lower glutathione and glutamate than younger participants. There was no significant effect of APOE or an interaction between APOE and age on the metabolite profile. Our data suggest that creatine, a commonly used reference metabolite in H-MRS studies, does not remain stable across adulthood within this region and therefore may not be a suitable reference in studies involving a broad age-range. Increases in creatine and myo-inositol may reflect age-related glial proliferation; decreases in glutamate and glutathione suggest a decline in synaptic and antioxidant efficiency. Our findings inform longitudinal clinical studies by characterizing age-related metabolite changes in a non-clinical sample.
Similar content
Preprint
Repeated unilateral handgrip contractions alter functional connectivity and improve contralateral limb response times: A neuroimaging study
Preprint
The effects of varying intensities of unilateral handgrip fatigue on bilateral movement
Paper
The Effects of Theta-Gamma Peak Stimulation on Sensorimotor Learning During Speech Production
2025. Neurobiology of Language, 6.
Paper
Baclofen, a GABAb receptor agonist, impairs motor learning in healthy people and changes inhibitory dynamics in motor areas.
2025. Imaging Neurosci (Camb), 3.
Free Full Text at Europe PMC